This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Requires companies that sell direct-to-consumer genetic tests to give people clear access to and control over their genomic data and biological samples, including the ability to request deletion or destruction. Companies must notify consumers about those rights and about possible sharing of deidentified genomic data; they must comply with deletion/destruction requests within 30 days (subject to narrow legal or regulatory retention exceptions). The Federal Trade Commission enforces the rules and may issue implementing regulations within a year.
The bill gives consumers stronger rights and clearer notice over genomic data and creates an FTC enforcement path, but significant privacy risks (reidentification), legal exceptions to deletion, enforcement limitations, and compliance costs remain.
Patients and direct-to-consumer genetic testing customers can obtain, export, or require destruction of their genomic data and biological samples, and companies must comply within 30 days, giving individuals stronger control over sensitive genetic information.
Consumers gain a federal enforcement path because the FTC is granted rulemaking and enforcement authority to deter misuse of genomic data and provide remedies for violations.
Consumers will receive clearer notices about possible sharing of deidentified genomic data for research, improving transparency about downstream uses of their genetic information.
Consumers' deidentified genomic data can still be reidentified and the bill relies on commitments and downstream use limitations that may be imperfectly enforced, leaving privacy risks.
Consumers may remain unable to delete data or samples when retention is required by warrants, subpoenas, or other legal or regulatory obligations, limiting the practical scope of deletion rights.
Relying on the FTC as the primary regulator may result in slower or more limited enforcement compared with a dedicated health privacy regulator, and gaps or inconsistencies with HIPAA could create enforcement complexity for consumers.
Introduced March 5, 2025 by Bill Cassidy · Last progress March 5, 2025